Nathan Rigby
Nathan Rigby works within the US market, specialising in in-vitro diagnostics. He enjoys exploring the humanitarian benefits of IVD and the development of new diagnostic tests for early cancer detection and infectious disease.
"It doesn't matter where you come from, people want to partner with an employer that's making a difference in the world."
I'm Nathan Rigby, a business consultant that specialises in global, executive recruitment for the in-vitro diagnostics market.
In this episode of CM Conversations, I welcomed CJ Harris onto the podcast.
CJ is a champion of diversity and inclusion. She has a wealth of experience in the life science sector, currently working as leader of the talent acquisition and learning development team at Luminex Corporation.
Luminex is a biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life sciences. Thanks to CJ, it also has a forward-thinking recruitment strategy that embraces diversity and inclusion.
I wanted to find out about the successes and challenges CJ has experienced, building diverse and inclusive teams in the life science arena.
If you’d like to speak to me about the podcast, please email Nathan.Rigby@lifesci-cm.com.
For more content like this, visit my consultant page.
Recommended.
-
30 March 2022What are the Key Market Barriers within Liquid Biopsy? Part 2 with Dennis Merkle, CEO of Predicine Europe.
In part two of this discussion, Dennis and I discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering a new market. Click to listen.
-
14 March 2022
Why is Liquid Biopsy So Important? Part 1 with Dennis Merkle, CEO of Predicine Europe.
Predicine With a background in research, pharma and commercial, Dennis gives insight into the true value of liquid biopsy. Click to listen.
-
24 February 2022Approaching Market Access in Europe with Director of Market Development at Adaptive Biotechnologies.
This is the first in a new CM Life Science series discussing trends and insights into the diagnostics market. Here I'm joined by Delphine, to discuss European market expansion strategies within the diagnostics space. Click to listen.
Comments.